Menu
 
Research menu
Jump to menu

Publications:  Miss Elzbieta Stankiewicz

Xu L, Mao X, Guo T, Chan PY, Shaw G, Hines J, Stankiewicz E, Wang Y et al.(2017). The novel association of circulating tumor cells and circulating megakaryocytes with prostate cancer prognosis. Clin Cancer Res
10.1158/1078-0432.CCR-16-3081
Mao X, Luo F, Boyd LK, Zhou B, Zhang Y, Stankiewicz E, Marzec J, Vasiljevic N et al.(2016). NKAIN2 functions as a novel tumor suppressor in prostate cancer. Oncotarget
10.18632/oncotarget.11690
La-Touche S, Lemetre C, Lambros M, Stankiewicz E, Ng CKY, Weigelt B, Rajab R, Tinwell B et al.(2016). DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes. PLoS One vol. 11, (2)
10.1371/journal.pone.0146740
Mao X, Li J, Xu X, Boyd LK, He W, Stankiewicz E, Kudahetti SC, Cao G et al.(2014). Involvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancer. Am J Cancer Res vol. 4, (6) 886-896.
Ren G, Liu X, Mao X, Zhang Y, Stankiewicz E, Hylands L, Song R, Berney DM et al.(2012). Identification of frequent BRAF copy number gain and alterations of RAF genes in Chinese prostate cancer. Genes Chromosomes Cancer vol. 51, (11) 1014-1023.
10.1002/gcc.21984
Ren G, Liu X, Mao X, Zhang Y, Stankiewicz E, Hylands L, Song R, Berney DM et al.(2012). Identification of frequent BRAF copy number gain and alterations of RAF genes in chinese prostate cancer. Genes Chromosomes and Cancer vol. 51, (11) 1014-1023.
10.1002/gcc.21984
Jeetle SS, Fisher G, Yang ZH, Stankiewicz E, Møller H, Cooper CS, Cuzick J, Berney DM et al.(2012). Neuroendocrine differentiation does not have independent prognostic value in conservatively treated prostate cancer. Virchows Arch vol. 461, (2) 103-107.
10.1007/s00428-012-1259-2
Boyd LK, Mao X, Xue L, Lin D, Chaplin T, Kudahetti SC, Stankiewicz E, Yu Y et al.(2012). High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer. Genes Chromosomes Cancer vol. 51, (6) 579-589.
10.1002/gcc.21944
Stankiewicz E, Ng M, Cuzick J, Mesher D, Watkin N, Lam W, Corbishley C, Berney DM(2012). The prognostic value of Ki-67 expression in penile squamous cell carcinoma. J Clin Pathol vol. 65, (6) 534-537.
10.1136/jclinpath-2011-200638
Xue L, Mao X, Ren G, Stankiewicz E, Kudahetti SC, Lin D, Beltran L, Berney DM et al.(2012). Chinese and Western prostate cancers show alternate pathogenetic pathways in association with ERG status. Am J Cancer Res vol. 2, (6) 736-744.
Jeetle S, Yang ZH, Stankiewicz E, Fisher G, Cuzick J, Berney D(2011). Long-term outcome and neuroendocrine differentiation in conservatively treated prostate cancers. VIRCHOWS ARCHIV vol. 459, S59-S59.
Bastus NC, Lu Y-J, Boyd LK, Mao X, Stankiewicz E, Kudahetti SC, Oliver TD, Berney DM(2011). Enhanced androgen signalling pathway increases the risk of prostate cancer through induction of TMPRSS2:ERG fusion. CANCER RESEARCH vol. 71,
10.1158/1538-7445.AM2011-3048
Boyd LK, Xue L, Mao X, Lin D, Chaplin T, Kudahetti SC, Stankiewicz E, Bisson I et al.(2011). Monoclonal origin of multifocal cancer and the step-wise genetic events of prostate carcinogenesis. CANCER RESEARCH vol. 71,
10.1158/1538-7445.AM2011-4831
Lu Y-J, Mao X, Xue L, Boyd LK, Kudahetti SC, Yu Y, Ren G, Lin D et al.(2011). The different genetic alterations between Western and Chinese samples indicate alternate pathways of prostate cancer development. CANCER RESEARCH vol. 71,
10.1158/1538-7445.AM2011-3878
Stankiewicz E, Prowse DM, Ng M, Cuzick J, Mesher D, Hiscock F, Lu Y-J, Watkin N et al.(2011). Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One vol. 6, (3)
10.1371/journal.pone.0017517
Cuzick J, Swanson GP, Fisher G, Brothman AR, Berney DM, Reid JE, Mesher D, Speights VO et al.(2011). Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol vol. 12, (3) 245-255.
10.1016/S1470-2045(10)70295-3
Stankiewicz E, Prowse DM, Ktori E, Cuzick J, Ambroisine L, Zhang X, Kudahetti S, Watkin N et al.(2011). The retinoblastoma protein/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma. Histopathology vol. 58, (3) 433-439.
10.1111/j.1365-2559.2011.03762.x
Bastus NC, Boyd LK, Mao X, Stankiewicz E, Kudahetti SC, Oliver RTD, Berney DM, Lu Y-J(2010). Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells. Cancer Res vol. 70, (23) 9544-9548.
10.1158/0008-5472.CAN-10-1638
Mao X, Yu Y, Boyd LK, Ren G, Lin D, Chaplin T, Kudahetti SC, Stankiewicz E et al.(2010). Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis. Cancer Res vol. 70, (13) 5207-5212.
10.1158/0008-5472.CAN-09-4074
Stankiewicz E, Kudahetti SC, Prowse DM, Ktori E, Cuzick J, Ambroisine L, Zhang X, Watkin N et al.(2009). HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis. Mod Pathol vol. 22, (9) 1160-1168.
10.1038/modpathol.2009.77
Berney DM, Stankiewicz E, Adlan AMA, Kudahetti S, Biedrzycki OJ, Hadway P, Watkin N, Corbishley C(2008). DNA topoisomerase I and IIalpha expression in penile carcinomas: assessing potential tumour chemosensitivity. BJU Int vol. 102, (8) 1040-1044.
10.1111/j.1464-410X.2008.07698.x
Return to top